1. Home
  2. CURI vs CTMX Comparison

CURI vs CTMX Comparison

Compare CURI & CTMX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CuriosityStream Inc.

CURI

CuriosityStream Inc.

HOLD

Current Price

$4.62

Market Cap

257.8M

ML Signal

HOLD

Logo CytomX Therapeutics Inc.

CTMX

CytomX Therapeutics Inc.

HOLD

Current Price

$4.16

Market Cap

596.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CURI
CTMX
Founded
N/A
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Movies/Entertainment
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
257.8M
596.2M
IPO Year
N/A
2015

Fundamental Metrics

Financial Performance
Metric
CURI
CTMX
Price
$4.62
$4.16
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
6
Target Price
$6.00
$6.50
AVG Volume (30 Days)
768.8K
2.0M
Earning Date
11-12-2025
11-06-2025
Dividend Yield
6.65%
N/A
EPS Growth
N/A
50.22
EPS
N/A
0.24
Revenue
$66,595,000.00
$113,631,000.00
Revenue This Year
$42.19
N/A
Revenue Next Year
$7.55
N/A
P/E Ratio
N/A
$17.32
Revenue Growth
28.62
N/A
52 Week Low
$1.47
$0.40
52 Week High
$7.15
$4.62

Technical Indicators

Market Signals
Indicator
CURI
CTMX
Relative Strength Index (RSI) 50.58 57.36
Support Level $4.42 $3.78
Resistance Level $5.00 $4.20
Average True Range (ATR) 0.23 0.24
MACD 0.02 -0.02
Stochastic Oscillator 34.48 73.88

Price Performance

Historical Comparison
CURI
CTMX

About CURI CuriosityStream Inc.

CuriosityStream Inc is a media and entertainment company. It offers premium video programming across the principal categories of factual entertainment, including science, history, society, nature, lifestyle, and technology. Its mission is to provide premium real entertainment that informs, enchants, and inspires. Its product and services are Direct to Consumer Business, Partner Direct Business, Bundled Distribution, Content Licensing, Enterprise Subscriptions and Others. The majority of the revenue comes from the Direct to direct-to-consumer business.

About CTMX CytomX Therapeutics Inc.

CytomX Therapeutics Inc a clinical-stage, oncology-focused biopharmaceutical company developing novel, masked, conditionally activated biologics designed to be localized to the tumor microenvironment. It is engaged in developing antibody therapeutics based on probody technology platforms. The company's probody technology platform creates proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.

Share on Social Networks: